Integrate substance use screening into primary care as a full SBIRT workflow (Screening, Brief Intervention, and Referral to Treatment), not as a questionnaire alone. The practice selects a validated screen, defines the population, responds to each result, addresses urgent needs, and makes referral and follow-up possible.
Who should the workflow cover?
Decide whether the workflow covers alcohol, other substances, or both. Name the age group, setting, exclusions, languages, frequency, and responsible staff. Do not borrow a cutoff or schedule from a different population.
The current final USPSTF recommendation for unhealthy alcohol use dates from 2018. It supports screening adults 18 and older in primary care, including during pregnancy. It also supports brief behavioral counseling for people engaged in risky or hazardous drinking.
Keep the claim narrow. The Task Force found insufficient evidence to recommend for or against that approach in adolescents aged 12 to 17. Pediatric guidance and local requirements need a separate review. An alcohol recommendation does not automatically establish the same benefit, instrument, cutoff, or intervention for every drug or age group.
Which screen should you use?
Name the exact form and confirm its respondent, timeframe, substances covered, language, scoring key, validated population, cutoff, missing-answer rule, and permission for the intended use. A screen identifies who may need a conversation or fuller assessment. It does not diagnose a substance use disorder, determine withdrawal risk, or select a level of care by itself.
Short and long forms are not interchangeable, and neither are current-use and lifetime measures. The CAGE, for example, asks about lifetime alcohol-related experiences and should not be presented as a current-use result. A practice may follow a positive brief screen with a longer assessment. If so, document the trigger and how staff record both results.
How do you connect screening, brief intervention, and referral?
SAMHSA describes SBIRT as an integrated public-health approach with three parts, and its systems-level implementation guide describes the core elements of SBIRT programs. Turn each part into a local decision map that staff can use during a visit.
Screening quickly assesses substance-use severity and the possible level of need. For each possible result, state who reviews it and what further assessment occurs.
Brief intervention builds awareness and motivation toward change. Define what can happen during the visit, and do not use the same script for everyone. A brief intervention should reflect the substance, result, health context, and patient's goals. It is not a substitute for treatment when the clinical assessment shows a greater level of need.
Referral to treatment connects a person who needs more extensive care with specialty services. Define when staff try a warm handoff and how they record the next step.
Where does screening fit in the visit?
The screen can be completed before the visit, during rooming, or in conversation when the instrument supports that mode. Choose the point that gives the responsible clinician enough time to review and respond. Give every screen a visible state: not offered, declined, started but incomplete, or complete and waiting for review. Once reviewed, it should show a documented next step or an escalation for urgent assessment.
Private completion conditions and a clear explanation of why the practice asks can support honest responses. Keep an accessible alternative for people who cannot use the digital route. The digital survey adoption guide covers the choice between digital and other collection methods.
What should staff do about urgent needs?
Before routine screening begins, define what staff do for urgent concerns. These may include intoxication, overdose, severe withdrawal, impaired driving, violence, pregnancy-related risk, or inability to care for a dependent. Alcohol and sedative withdrawal can become a medical emergency. A questionnaire cannot show whether someone can stop without medical support. Pause routine screening and address the urgent need.
The addiction recovery tracking guide explains why symptom scores should not guide detoxification or tapering. Use emergency services or an appropriate urgent clinical evaluation when immediate medical danger is possible.
If the screen or conversation raises suicide or self-harm concerns, follow the practice's separate direct-assessment and emergency pathway. Do not infer safety from a substance-use total.
If you need help now. In the US, Call 988 or text 988. Call 911 if you are in immediate danger. Outside the US, contact your local emergency number or find support in your country.
How do you build referral capacity?
A referral list is not a completed referral, and capacity changes. Verify which services accept the population, substances, insurance, language, and level of care in question, then check again before launch. Record how staff handle unavailable appointments, transportation, cost, telehealth access, and consent to share information.
Plan for refusal. Decide whether the practice will schedule while the patient is present, send information with consent, confirm receipt, and follow up after a missed connection. Keep medication treatment and withdrawal-management options current where they are within the practice's scope.
How do you test and review the workflow?
Before launch, test routine and difficult paths with non-patient cases. Include a negative result, a result needing brief intervention, an incomplete screen, and an urgent medical concern. Also test an unavailable referral and a person who declines the next step.
After launch, audit the whole path, including the misses. Useful measures include recorded offers, complete review states, brief interventions when indicated, referral attempts, successful connections, unresolved urgent cases, and time to follow-up. A high screening rate with no response is not a successful SBIRT program.
The Collaborative Care guide covers a separate team-based model for ongoing behavioral health care. Both workflows need defined ownership, visible exceptions, and a clinical response beyond questionnaire delivery. Fix any path that ends without a documented next step before you widen the population or add substances.